Syndax Pharmaceuticals Stock Price - SNDX

0.00 (0.00%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Syndax Pharmaceuticals Inc SNDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.34 -12.47% 9.41 9.11 10.70 10.50 10.75 17:15:00
Bid Price Ask Price Spread Spread % News
9.41 10.75 1.34 12.47% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,049 395,643 $ 9.94 $ 3,933,548 257,334 4.30 - 11.33
Last Trade Time Type Quantity Stock Price Currency
16:00:06 8 $ 9.41 USD

Syndax Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 255.39M 27.14M $ -73.96M -2.92 - 27.09M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Syndax Pharmaceuticals News

Loading Messages....

Latest SNDX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNDX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week10.9410.979.1110.57204,004-1.53-13.99%
1 Month8.1711.337.009.86352,8701.2415.18%
3 Months8.8311.336.329.26191,1010.586.57%
6 Months8.7211.335.358.31166,1310.697.91%
1 Year6.1711.334.307.87165,0593.2452.51%
3 Years11.1715.703.398.88222,909-1.76-15.76%
5 Years12.1118.033.399.24189,663-2.70-22.3%

Syndax Pharmaceuticals Description

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidate are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Your Recent History
Syndax Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.